510(k) K781951
K781951 is an FDA 510(k) premarket notification submitted by Kallestad Laboratories, Inc. for the device "ANTISERA, RHODAMINE CONJUGATED FRAGMENT". The FDA issued a decision of Substantially Equivalent on February 16, 1979. The device falls under product code DCE (Fab, Antigen, Antiserum, Control), a Class I device regulated under 21 CFR 866.5520. Kallestad Laboratories, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 16, 1979
- Date Received
- November 21, 1978
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Fab, Antigen, Antiserum, Control
- Device Class
- Class I
- Regulation Number
- 866.5520
- Review Panel
- IM
- Submission Type